米非司酮联合米索前列醇用于药物流产的疗效及安全性分析

发布时间：2017-12-31 16:37

  本文关键词：米非司酮联合米索前列醇用于药物流产的疗效及安全性分析　出处：《中国卫生标准管理》2016年20期 　论文类型：期刊论文

  更多相关文章： 米非司酮 米索前列醇 药物流产

【摘要】：目的对米非司酮联合米索前列醇用于药物流产的疗效及安全性进行分析。方法 100例孕妇根据随机数字表法分为各50例的观察组与对照组,对照组给予口服米索前列醇,观察组给予口服米非司酮联合米索前列醇。结果观察组完全流产率高于对照组,阴道流血量,阴道流血时间及胚胎排出时间与不良反应发生率低于对照组,差异均具有统计学意义(P0.05)。结论采用米非司酮与米索前列醇联合的药物流产方法能够获得较高的药物流产率,且降低阴道出血量。
[Abstract]:Objective to analyze the efficacy and safety of mifepristone combined with misoprostol in the treatment of drug abortion. Methods 100 pregnant women were divided into two groups according to random number table: observation group (n = 50) and control group (n = 50). The control group was given oral misoprostol and the observation group was given mifepristone combined with misoprostol. Results the rate of complete abortion in the observation group was higher than that in the control group and the amount of vaginal bleeding was higher. Vaginal bleeding time, embryo excretion time and the incidence of adverse reactions were lower than those in the control group. Conclusion the combination of mifepristone and misoprostol can obtain higher drug abortion rate and reduce vaginal bleeding.
【作者单位】： 河南省驻马店市上蔡县人民医院妇产科;
【分类号】：R169.42
【正文快照】： 目前人为流产的方法包括药物流产与手术流产两种方式,药物流产是通过服用终止妊娠药物进行流产的方法,与手术流产方法相比,药物流产能够降低手术带来的恐惧感,降低疼痛与并发症的发生,从而达到终止早期妊娠,并保障安全的目的[1]。本文以100例需要终止妊娠的健康孕妇为研究对象，

本文编号：1360601